Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Origin Sciences Puts Weinberger At The Helm

This article was originally published in Clinica

Executive Summary

Origin Sciences, an emerging UK firm focused on gastrointestinal disease detection and monitoring, has appointed Paul Weinberger as CEO and director. Weinberger is the first to fill this position; prior to the appointment, the responsibilities of chief executive had been split between Origin’s senior management team. The new CEO’s track record includes “high level roles” at various diagnostic firms such as Lumora, Enigma Diagnostics and Roche Diagnostics. He is also founder and CEO of Diasolve, which helps inventors and companies bring innovative diagnostic solutions to market. Origin last year launched OriCol, a sampling device for investigating gastrointestinal disease, and has been expanding its international commercial presence.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst